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Background
Semicarbazide-sensitive amine oxidase (SSAO) is an
enzyme that performs oxidative deamination of primary
amines to aldehyde, ammonia and hydrogen peroxide. It
appears that these products may have important signalling
function in the regulation of cell development and glucose
homeostasis. Much attention has been given to raised
plasma SSAO activity in diabetic patients, both types 1
and 2. We were interested whether the peroral antidiabetic
drug metformin affects SSAO activity in vitro. In this
study we used metformin because it is usually the first-line
medication used for treatment of type 2 diabetes.
Methods
First we studied the activity of SSAO in 15 different gui-
nea-pig tissues with radiochemical methods. Two of 15
tissues (liver and kidney) were also used for the in vitro
experiment, in which preincubation with metformin or
the SSAO inhibitor semicarbazide was performed. Tissue
homogenates were used for protein quantification using
the Bradford method and for determination of SSAO
activity using radioactive [14C]benzylamine as substrate.
Since benzylamine is also a substrate for MAO-B, the
MAO-B inhibitor deprenyl was added to the incubation
mix. After 30 min of incubation at 37°C in sodium phos-
phate buffer the reaction was stopped by addition of
perchloric acid. The product [14C]benzaldehyde was
extracted into toluene containing 0.6% 2,5-diphenyloxa-
zol. We measured radioactivity in the organic phase with
a liquid scintillation counter.
Results
The highest concentration of SSAO was determined in
the gastrointestinal system, especially in the liver (32 ±
4.0 mU/mg protein). Relatively high SSAO activity was
found also in the spleen (47 ± 4.8 mU/mg protein),
abdominal artery (39 ± 8.5 mU/mg protein), skin (32 ±
9.0 mU/mg protein), kidney (33 ± 4.7 mU/mg protein)
and lung (26 ± 2.6 mU/mg protein). Smaller amounts of
SSAO were present in pancreas and brain. Our results
indicated that metformin had no effect on SSAO activity
in vitro. As expected, semicarbazide decreased SSAO
activity in a concentration-dependent manner.
Conclusions
SSAO appears to have an important role in the gastroin-
testinal system of the guinea-pig. The high SSAO concen-
tration in the liver is probably due to the detoxifying
function of this tissue. The relatively high SSAO levels in
the lung could protect the animals from inhaled methyla-
mine and other volatile amines. We conclude that SSAO
activity is probably not affected during treatment with the
antidiabetic drug metformin.
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